Ask the Mayo Mom: The eyes of a child

Ask the Mayo Mom: The eyes of a child

Dr. Brittni Scruggs, an ophthalmologist at Mayo Clinic Children’s Center discusses retinal issues and eye safety in children. Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy

Jaksot(473)

What young men need to know about testicular cancer

What young men need to know about testicular cancer

While testicular cancer is rare compared with other types of cancer, it is the most common cancer in American males ages 15 to 35. Testicular cancer is highly treatable, even when cancer has spread beyond the testicle. Several treatments or a combination of treatments are available, and long-term survival rates are greater than 90%. As a part of men's health and the Movember Foundation's focus on testicular cancer, Dr. Matthew Ziegelmann, a Mayo Clinic urologist, joins the Mayo Clinic Q&A podcast to discuss diagnosis and treatment of testicular cancer. Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy

19 Marras 202014min

Men’s health – Treating erectile dysfunction

Men’s health – Treating erectile dysfunction

When it comes to medical care, men are less likely to seek care than women. While men may typically avoid seeing their health care provider, some problems often prompt them to take action. One complaint that can bring men to the doctor's office is erectile dysfunction, which is the inability to get and keep an erection firm enough for sex. Since erectile dysfunction also can be a sign of an underlying health condition that needs treatment, and it is a risk factor for heart disease, it is important for men to talk to their health care provider. On the Mayo Clinic Q&A podcast, Dr. Sevann Helo, a Mayo Clinic urologist, discusses men's sexual health and treatments for erectile dysfunction, as well as male infertility. Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy

18 Marras 202013min

COVID-19 vaccine trials update

COVID-19 vaccine trials update

While the number of COVID-19 cases continues to surge, there is positive news on the vaccine front. In early clinical trial data, two vaccines have now shown at least 90% effectiveness in reducing the risk of infection from the virus that causes COVID-19. While more time and research is needed to understand how long the immunity from a vaccine lasts, experts believe a vaccine could be approved for emergency use authorization before the end of the year. On the Mayo Clinic Q&A podcast, Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group, discusses the latest on current COVID-19 clinical trials. Dr. Poland also explains what public health experts mean by community spread of the virus and why that leads to exponential growth in cases of COVID-19. Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy

17 Marras 202019min

Epilepsy Awareness Month

Epilepsy Awareness Month

Epilepsy is a neurological disorder that affects the central nervous system and causes seizures. More than 3 million Americans and more than 65 million people worldwide have epilepsy - a key reason that November is recognized as National Epilepsy Awareness Month. Thankfully, treatment with medications or sometimes surgery can control seizures for most people with epilepsy. On the Mayo Clinic Q&A podcast, Dr. Joseph Sirven, a Mayo Clinic neurologist, discusses the importance of raising awareness of epilepsy to lessen the stigma, Dr. Sirven also highlights the latest in treatments and research. Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy

16 Marras 202018min

Cardiometabolic diseases increase COVID-19 risk

Cardiometabolic diseases increase COVID-19 risk

An estimated 47 million Americans are living with cardiometabolic diseases, according to the American College of Cardiology. Cardiometabolic diseases are interrelated conditions that include cardiovascular diseases, such as heart disease, stroke, and hypertension, as well as metabolic diseases, such as Type 2 diabetes, obesity and nonalcoholic fatty liver disease. Patients with cardiometabolic diseases have a higher risk of not only developing COVID-19, but also developing complications related to COVID-19. On the Mayo Clinic Q&A podcast, Dr. Stephen Kopecky, a Mayo Clinic cardiologist, discusses lifestyle factors that affect cardiometabolic diseases and how COVID-19 can damage the heart. Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy

13 Marras 202011min

Mayo Clinic Laboratories helps in COVID-19 fight

Mayo Clinic Laboratories helps in COVID-19 fight

When the COVID-19 pandemic began, one of the areas of science and research most affected was laboratory medicine. From developing tests that detect the virus, to testing for antibodies in patients who have recovered, Mayo Clinic Laboratories has been at the forefront of COVID-19 testing and research. On the Mayo Clinic Q&A podcast, Dr. William Morice II, president of Mayo Clinic Laboratories and chair of the department of Laboratory Medicine and Pathology at Mayo Clinic, explains how a reference lab works and how Mayo Clinic Laboratories quickly ramped up its testing capability to meet pandemic testing needs. Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy

12 Marras 202016min

US tops 10 million cases of COVID-19

US tops 10 million cases of COVID-19

The U.S. reached the wrong kind of milestones this past week, reporting the 10 millionth coronavirus case and daily infection rates repeatedly topping the 100,000 mark. Cases of COVID-19 have been spiking for weeks as a third wave of infections spreads across the country. On the Mayo Clinic Q&A podcast, Dr. Gregor (https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721&_ga=2.136537328.1903245515.1583502589-382127956.1576426874)y Poland (https://www.mayoclinic.org/biographies/poland-gregory-a-m-d/bio-20053165?utm_source=newsnetwork&utm_medium=l&utm_content=content&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100721&_ga=2.136537328.1903245515.1583502589-382127956.1576426874), an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group, discusses the growing number of coronavirus cases in the U.S. and across Europe, and what can be done to reverse the trends. Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy

11 Marras 202015min

‘Movember’ movement raises prostate cancer awareness

‘Movember’ movement raises prostate cancer awareness

After skin cancer, prostate cancer is the most common cancer among men. In the U.S., 1 in 9 men will be diagnosed with prostate cancer in their lifetime. Prostate cancer that's detected early — when it's still confined to the prostate gland — has a better chance to be successfully treated, so it's important that men know their risk factors. The "Movember" movement is encouraging men to grow a mustache in November to raise awareness of men's health issues, including prostate cancer. On the Mayo Clinic Q&A podcast, Dr. Raymond Pak, a Mayo Clinic urologist, explains the guidelines for prostate screening and when to get a second opinion. Dr. Pak also shares the latest advances in treatment for prostate cancer. Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy

10 Marras 202023min

Suosittua kategoriassa Tiede

rss-mita-tulisi-tietaa
utelias-mieli
tiedekulma-podcast
hippokrateen-vastaanotolla
docemilia
rss-lihavuudesta-podcast
filocast-filosofian-perusteet
rss-poliisin-mieli
rss-duodecim-lehti
rss-ammamafia
sotataidon-ytimessa
menologeja-tutkimusmatka-vaihdevuosiin
vinkista-vihia
radio-antro
rss-ranskaa-raakana
rss-tiedetta-vai-tarinaa
rss-ilmasto-kriisissa
rss-jyvaskylan-yliopisto
rss-luontopodi-samuel-glassar-tutkii-luonnon-ihmeita